Trials / Completed
CompletedNCT01700933
Dose-response: Exercise Therapy on Hip Osteoarthritis
Dose-response: Exercise Therapy on Hip Osteoarthritis, a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
Osteoarthritis is a common disease that causes muscle weakness, stiffness and instability. The disease reduces the opportunities for an active lifestyle. Exercise Therapy provides a well-documented effect on pain and function in patients with osteoarthritis of the hip. It is sought an optimal dose of exercise, in which this study will help to investigate. We hypothesize that an exercise program designed to have a high number of repetitions will benefit the outcome of the training in a more positive way than a low-repetition based program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High-Dosage Exercise Therapy | Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) |
| OTHER | Low-Dosage Exercise Therapy | Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2012-10-04
- Last updated
- 2017-09-21
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01700933. Inclusion in this directory is not an endorsement.